Seik-Soon Khor Selected Research

HLA-A*02:06:01 antigen

11/2019

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seik-Soon Khor Research Topics

Disease

7	Narcolepsy 12/2018 - 01/2013
4	Cataplexy 12/2018 - 01/2013
3	Disorders of Excessive Somnolence (Hypersomnia) 12/2018 - 01/2013
2	COVID-19 04/2022 - 01/2021
2	Hepatitis B 01/2021 - 01/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 01/2016
2	Panic Disorder (Panic Attack) 01/2016 - 05/2015
2	Sleep Wake Disorders 02/2015 - 01/2013
1	Neoplasms (Cancer) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Non-alcoholic Fatty Liver Disease 08/2020
1	Infections 01/2020
1	Disease Susceptibility (Diathesis) 11/2019
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2019
1	Graves Disease (Basedow Disease) 01/2019
1	Moyamoya Disease (Moya-Moya Disease) 01/2019
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2019
1	Thyroid Diseases (Thyroid Disease) 01/2019
1	Crohn Disease (Crohn's Disease) 11/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Disease Progression 01/2018
1	Idiopathic Hypersomnia 01/2015

Drug/Important Bio-Agent (IBA)

6	HLA Antigens (Human Leukocyte Antigens)IBA 08/2020 - 02/2015
6	HLA-DQB1 antigen (HLA DQB1)IBA 12/2018 - 01/2013
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 05/2015
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2018
2	VaccinesIBA 01/2021 - 01/2018
2	HLA-DRB1*04 antigenIBA 01/2019 - 01/2018
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2018
1	Immunoglobulin G (IgG)IBA 04/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022
1	HLA-B*52:01 antigenIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	HLA-C Antigens (HLA-C)IBA 01/2021
1	HLA-DR beta-ChainsIBA 08/2020
1	Glycoproteins (Glycoprotein)IBA 08/2020
1	HLA-B Antigens (HLA-B)IBA 08/2020
1	HLA-DQ Antigens (HLA-DQ)IBA 08/2020
1	myosin light chain 2IBA 08/2020
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020
1	HLA-A*02:06:01 antigenIBA 11/2019
1	Amino Acids FDA Link 11/2018
1	AntibodiesIBA 01/2018
1	HLA-DQA2 antigenIBA 01/2018
1	EpitopesIBA 01/2018
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2016
1	Purinergic Receptors (Receptors, Purine)IBA 10/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016
1	GTP-Binding Proteins (G-Protein)IBA 10/2016
1	CC ChemokinesIBA 10/2015
1	OrexinsIBA 05/2014
1	NeuropeptidesIBA 05/2014

Therapy/Procedure

1	Therapeutics 01/2022
1	Immunotherapy 01/2022